Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 20, 2024 · Filed Dec 23, 2024
A Nexgel director sold $14K of Nexgel shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$13,935
Shares × reported transaction price
36 days after results of Nov 14, 2024, 33 days before results of Jan 22, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −5.9% | −2.5% | −3.4% |
| 30 days | −28.3% | +1.4% | −29.7% |
| 90 days | −34.8% | −4.5% | −30.3% |
| 180 days | −50.2% | −0.2% | −50.0% |
| 365 days | −66.5% | +14.8% | −81.3% |
Past results only. Not a forecast.
Scott Robert Henry (Director) sold ~$10K of Nexgel
Planned saleAdam R. Levy (Chief Executive Officer) sold ~$16K of Nexgel
Planned saleInsider buying
Traded Nov 20, 2024 · filed 2 days later
The CFO of Nexgel paid $48K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.